Large‐Scale Production of Wholly Cellular Bioinks via the Optimization of Human Induced Pluripotent Stem Cell Aggregate Culture in Automated Bioreactors (Adv. Healthcare Mater. 24/2022)

3D Bioprinting In article 2201138, Mark Skylar‐Scott and co‐workers establish a billion cell‐scale bioprinting pipeline. Human induced pluripotent stem cells are cultured and passaged in automated bioreactors and compacted into wholly cellular bioinks for bioprinting and differentiation. Artwork: Ty...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Advanced healthcare materials 2022-12, Vol.11 (24), p.n/a
Hauptverfasser: Ho, Debbie L. L., Lee, Stacey, Du, Jianyi, Weiss, Jonathan D., Tam, Tony, Sinha, Soham, Klinger, Danielle, Devine, Sean, Hamfeldt, Art, Leng, Hope T., Herrmann, Jessica E., He, Mengdi, Fradkin, Lee G., Tan, Tze Kai, Standish, David, Tomasello, Peter, Traul, Donald, Dianat, Noushin, Ladi, Rukmini, Vicard, Quentin, Katikireddy, Kishore, Skylar‐Scott, Mark A.
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:3D Bioprinting In article 2201138, Mark Skylar‐Scott and co‐workers establish a billion cell‐scale bioprinting pipeline. Human induced pluripotent stem cells are cultured and passaged in automated bioreactors and compacted into wholly cellular bioinks for bioprinting and differentiation. Artwork: Tyson Teck Yang Tan.
ISSN:2192-2640
2192-2659
DOI:10.1002/adhm.202270149